Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Bacterial Infections Are a Factor in Many H1N1 Deaths
WEDNESDAY, Sept. 30 (HealthDay News) -- Many patients who have died of H1N1 influenza this year had a bacterial co-infection that likely contributed to their deaths, according to a Sept. 29 early release of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
H1N1 Virus's Genetic Makeup Appears to Be Staying Stable
MONDAY, Sept. 28 (HealthDay News) -- The genetic makeup of the H1N1 flu has remained stable, which means the yet-to-be-released vaccine is likely to be a good match for the virus, the U.S. Centers for Disease Control and Prevention announced at a Sept. 25 media briefing.
Gene Mutations Linked to Hereditary Immunodeficiency
WEDNESDAY, Sept. 23 (HealthDay News) -- Gene mutations leading to a lack of DOCK8 protein in lymphocytes are associated with a hereditary combined immunodeficiency, according to a study published online Sept. 23 in the New England Journal of Medicine.
Widowhood Affects Sexual Infection Risk in Older Men
WEDNESDAY, Sept. 23 (HealthDay News) -- Older men may have an increased risk of sexually transmitted infections after losing a spouse, especially if they take medications for erectile dysfunction, according to a study published online Sept. 17 in the American Journal of Public Health.
Abstract
Full Text (subscription or payment may be required)
Review Advises Hand Washing, Other Antiviral Measures
WEDNESDAY, Sept. 23 (HealthDay News) -- Hand washing, wearing a mask, and isolating potential cases are all effective in interrupting the spread of viral respiratory infections and should be given greater attention when planning for widespread outbreaks, according to research published Sept. 22 in BMJ.
Spotlight on Social Networking Use Among Medical Students
TUESDAY, Sept. 22 (HealthDay News) -- A majority of medical schools report instances of medical students posting unprofessional content on social networking Web sites, including some instances of violations of patient confidentiality, according to a report in the Sept. 23/30 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
HIV Linked With Increased Risk of Premature Delivery
THURSDAY, Sept. 17 (HealthDay News) -- HIV-positive women receiving antiretroviral treatment are at higher risk of giving birth prematurely and delivering a low-birth-weight infant, according to a study in the September issue of the American Journal of Obstetrics & Gynecology.
Abstract
Full Text (subscription or payment may be required)
Taxes on Sugared Sodas Could Cut Consumption
WEDNESDAY, Sept. 16 (HealthDay News) -- Imposing a tax on sugar-sweetened beverages could reduce consumption and generate income for obesity reduction and healthy eating education interventions, according to an article published online Sept. 16 in the New England Journal of Medicine.
FDA Approves Four Vaccines for H1N1 Influenza
TUESDAY, Sept. 15 (HealthDay News) -- The U.S. Food and Drug Administration has approved four H1N1 influenza vaccines, according to a Sept. 15 news release issued by the agency.
Drug Interaction E-Alerts Show Benefit to Patient Safety
MONDAY, Sept. 14 (HealthDay News) -- Drug interaction alerts from electronic prescribing likely improve patient safety and reduce costs in outpatient care, despite the fact that over 90 percent of the alerts are overridden by physicians, according to a study in the Sept. 14 issue of Archives of Internal Medicine.
Opt-Out HIV Screening Well-Accepted by Adolescents
MONDAY, Sept. 14 (HealthDay News) -- A routine, opt-out screening process for HIV at a pediatric emergency department was well-accepted by adolescents and their guardians, according to research published online Sept. 14 in Pediatrics.
Abstract
Full Text (subscription or payment may be required)
Mutated H1N1 Virus Resistant to Antiviral Drug Oseltamivir
FRIDAY, Sept. 11 (HealthDay News) -- The discovery of H1N1 mutations resistant to the neuraminidase inhibitor oseltamivir in two adolescent girls sharing a cabin at a North Carolina camp prompted a new recommendation from the U.S. Centers for Disease Control and Prevention on the proper prophylactic use of antiviral drugs, according to a case report in the Sept. 11 issue of the CDC's Morbidity and Mortality Weekly Report.
Current Health Policy May Not Serve Young People Well
FRIDAY, Sept. 11 (HealthDay News) -- A high proportion of deaths in young people worldwide are due to intentional and unintentional injury, and the current adolescent health policy focus on HIV/AIDS and maternal mortality is not enough to prevent mortality amongst youngsters, according to a study in the Sept. 12 issue of The Lancet.
Abstract
Full Text (subscription or payment may be required)
Most H1N1 Flu Patients Don't Need Antiviral Medication
WEDNESDAY, Sept. 9 (HealthDay News) -- Antiviral medications should be used to treat H1N1 swine flu only in people who are hospitalized from the flu or are at high risk of complications from it, according to the U.S. Centers for Disease Control and Prevention.
H1N1 Vaccines Appear Safe for Adults, Children
MONDAY, Sept. 7 (HealthDay News) -- The new H1N1 swine flu vaccine appears to be as safe as the seasonal flu variety, according to experts from the U.S. National Institute of Allergy and Infectious Diseases; and, intravenous use of the antiviral zanamivir (Relenza) may provide a lifesaving alternative for severe cases of H1N1 pneumonitis, according to a report published online Sept. 4 in The Lancet.
More Information - Vaccines
The Lancet Case Report (subscription or payment may be required)
HIV-Associated Dementia Linked to Disease Subtype
FRIDAY, Sept. 4 (HealthDay News) -- HIV-associated cognitive impairment may be more common in persons who are infected with the HIV subtype D, according to a study in the Sept. 1 issue of Clinical Infectious Diseases.
Abstract
Full Text (subscription or payment may be required)
Academic Medical Centers Active and Diverse in Research
TUESDAY, Sept. 1 (HealthDay News) -- Research at academic medical centers is active and diverse, with nearly a quarter of life-science researchers receiving no funding, and relationships with industry more commonly seen among translational and clinical researchers than basic science researchers, according to a study in the Sept. 2 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)